Clade Therapeutics is a well-funded cell therapy company developing novel cell-based medicines for the treatment of cancer and other devastating diseases. The company, located in the heart of Cambridge was recently launched by an exceptional group of academic leaders and successful bioentrepreneurs converging stem cell biology, immunology, regenerative medicine, and gene editing into the next-generation of stem cell-derived medicines.
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Total raised: $87M
Founded date: 2020
Investors 1
| Date | Name | Website |
| 04.11.2021 | Syncona Pa... | synconaltd... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 03.11.2021 | Series A | $87M | - |
Mentions in press and media 2
| Date | Title | Description |
| 03.11.2021 | Clade Therapeutics Raises $87 Million Series A Financing to Realize the Potential of Cell Therapy | Clade’s iPSC immune cloaking and differentiation platform technology to address compatibility, durability, reproducibility and scalability of cell therapies CAMBRIDGE, Mass., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Clade Therapeutics, a biopharma... |
| 03.11.2021 | Clade Therapeutics Raises $87 Million Series A Financing to Realize the Potential of Cell Therapy | CAMBRIDGE, Mass., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Clade Therapeutics, a biopharmaceutical company focused on discovering and delivering scalable, off-the-shelf, next-generation stem cell-based medicines, today announced it has secured an ... |